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Background: ln Switzerland no HIV test is performed without the patient's consent based on a 
Voluntary Counseling and Testing policy (VCT). We hypothesized that a substantial proportion of 
patients going through an elective surgery falsely believed that an HIV test was performed on a 
routine basis and that the lack of transmission of result was interpreted as being. HIV negative. 
Method: Ali patients with elective orthopedic surgery during 2007 were contacted by phone in 
2008. A structured questionnaire assessed their belief about routine preoperative blood analysis 
(diabetes, coagulation function, HIV test and cholesterol level) as weil as result awareness and 
interpretation. Variables inciuded age and gender. Analysis were conducted using the software 
JMP 6.0.3. 
Results: 1123 patients were inciuded. 130 (12 %) were exciuded (Le. unreachable, unable to 
communicate on the phone, not operated). 993 completed the survey (89 %). Median age was 51 
(16-79). 50 % were female. 376 (38 %) patients thought they had an HIV test performed before 
surgery but none of them had one. 298 (79 %) interpreted the absence of result as a negative HIV 
test. A predictive factor to believe an HIV test had been done was an age below 50 years old (45 
% vs 33 % for 16-49 years old and 50-79 years old respectively, p < 0.001). No difference was 
observed between genders. 
Conclusion: ln Switzerland, nearly 40 % of the patients falsely thought an HIV test had been 
performed on a routine basis before surgery and were erroneously reassured about their HIV 
status. These results should either improve the information given to the patient regarding 
preoperative exams, or motivate public health policy to consider HIV opt-out screening instead of 
VCT strategy. 
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